Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database - ScienceDirect

21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy

Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK - ScienceDirect

Evidence for diagnosis of early chronic pancreatitis after three episodes of acute pancreatitis: a cross-sectional multicentre international study with experimental animal model

PDF) Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database

Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2) - The Lancet Gastroenterology & Hepatology

The Motherload of “rare” adverse events from the Covid-19 Bio Weapons, by Owen Owen Owen, Oct, 2023

PDF) Impact of education and continuous professional development in Portuguese Pharmacy Technicians attitude's to adverse drug reaction reporting system

Full article: Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review

Drug induced pancreatitis is the leading known cause of first attack acute pancreatitis in children - ScienceDirect